Medicare Enrolled
Dr. Francis Averill, MD
Pulmonary Disease · Clearwater, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Averill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Averill?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Averill
Dr. Francis Averill is a pulmonary disease specialist in Clearwater, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Averill performed 3,516 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Averill received a total of $287,113 from 59 pharmaceutical and/or device companies across 1373 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Averill is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in FL
$287,113 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 60749 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗3,516
Medicare services
Top 14% in FL for pulmonary disease
Not available
Unique patients (not deduplicated)
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
687 | $96 | $218 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
460 | $68 | $150 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
283 | $32 | $89 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
256 | $21 | $70 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
178 | $128 | $333 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
166 | $1 | $3 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
151 | $60 | $140 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
129 | $29 | $116 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
129 | $41 | $105 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
129 | $43 | $110 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
114 | $64 | $148 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
84 | $84 | $184 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
82 | $26 | $68 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
69 | $11 | $41 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
55 | $140 | $301 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
53 | $68 | $291 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
49 | $35 | $92 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
49 | $30 | $35 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
48 | $72 | $112 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
48 | $0 | $2 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $80 | $217 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
38 | $67 | $87 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $136 | $416 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
30 | $466 | $1,191 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $93 | $213 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
22 | $146 | $340 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
21 | $18 | $51 |
| Pneumococcal vaccine, 13-valent | 20 | $253 | $429 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
20 | $30 | $32 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
14 | $7 | $35 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
14 | $476 | $1,244 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
13 | $15 | $31 |
| New patient office visit, complex (60-74 min) | 11 | $173 | $422 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$287,113
Total received (2018-2024)
Avg $41,016/year across 7 years
Top 1% in FL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,373
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$94,616
2023
$50,224
2022
$48,502
2021
$46,002
2020
$17,014
2019
$8,955
2018
$21,800
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$80,331
Insmed, Inc.
$11,378
GlaxoSmithKline, LLC.
$464
Regeneron Healthcare Solutions, Inc.
$312
GENZYME CORPORATION
$249
Amgen Inc.
$213
JAZZ PHARMACEUTICALS INC.
$197
Boehringer Ingelheim Pharmaceuticals, Inc.
$173
HARMONY BIOSCIENCES LLC
$155
United Therapeutics Corporation
$128
Grifols USA, LLC
$120
Actelion Pharmaceuticals US, Inc.
$119
AstraZeneca UK Limited
$113
ANI Pharmaceuticals, Inc.
$110
Mannkind Corporation
$104
Mallinckrodt Hospital Products Inc.
$99
Harmony Biosciences Llc
$88
Novartis Pharmaceuticals Corporation
$77
Merck Sharp & Dohme LLC
$45
Bayer Healthcare Pharmaceuticals Inc.
$45
3B Medical, Inc.
$33
IDORSIA PHARMACEUTICALS US INC
$24
Paratek Pharmaceuticals, Inc.
$20
Electromed, Inc.
$18
Top 3 companies account for 97.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$146,845
GlaxoSmithKline, LLC.
$92,161
Insmed, Inc.
$17,001
United Therapeutics Corporation
$6,551
Harmony Biosciences LLC
$4,107
AstraZeneca UK Limited
$2,667
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,648
Olympus Corporation of the Americas
$2,362
HARMONY BIOSCIENCES LLC
$1,303
Regeneron Healthcare Solutions, Inc.
$1,034
Actelion Pharmaceuticals US, Inc.
$897
JAZZ PHARMACEUTICALS INC.
$890
GENZYME CORPORATION
$825
Grifols USA, LLC
$691
Novartis Pharmaceuticals Corporation
$582
Mylan Specialty L.P.
$567
Amgen Inc.
$551
Genentech USA, Inc.
$549
Mallinckrodt Hospital Products Inc.
$501
Bayer HealthCare Pharmaceuticals Inc.
$438
Takeda Pharmaceuticals U.S.A., Inc.
$366
Watermark Medical, Inc.
$280
IDORSIA PHARMACEUTICALS US INC
$242
Sunovion Pharmaceuticals Inc.
$213
Philips Electronics North America Corporation
$187
Teva Pharmaceuticals USA, Inc.
$187
Eisai Inc.
$183
Circassia Pharmaceuticals Inc
$181
Electromed, Inc.
$161
Jazz Pharmaceuticals Inc.
$161
ANI Pharmaceuticals, Inc.
$132
Astellas Pharma US Inc
$121
Axsome Therapeutics, Inc.
$118
Covis Pharma GmBH
$115
La Jolla Pharmaceutical Company
$112
Mannkind Corporation
$104
Shire North American Group Inc
$99
Regeneron Pharmaceuticals, Inc.
$95
Pulmonx Corporation
$92
Harmony Biosciences Llc
$88
Bayer Healthcare Pharmaceuticals Inc.
$88
Advanced Respiratory, Inc
$62
Inspire Medical Systems, Inc.
$56
ALK-Abello, Inc
$52
SANOFI-AVENTIS U.S. LLC
$45
Merck Sharp & Dohme LLC
$45
Pharming Healthcare, Inc.
$43
Paratek Pharmaceuticals, Inc.
$38
Inogen, Inc.
$38
Janssen Pharmaceuticals, Inc
$36
3B Medical, Inc.
$33
Merck Sharp & Dohme Corporation
$30
Vapotherm Inc
$25
Resmed Corp
$24
PFIZER INC.
$24
PORTOLA PHARMACEUTICALS, INC.
$23
Greer Laboratories, Inc.
$16
Gilead Sciences, Inc.
$14
ADVANCED RESPIRATORY, INC
$13
Top 3 companies account for 89.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8946) DS2 A cell core · ACTHAR · AFREZZA · AIR 11 · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · ARES HOME SLEEP TESTING DEVICE · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · CRESEMBA · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · Dymista · Esbriet · FARXIGA · FASENRA · GIAPREZA · GLASSIA · Grastek · HYQVIA · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · InogenOne · LONHALA MAGNAIR · LUNA · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORALAIR · ORENITRAM · Odactra · Olympus EBUS Bronchoscopes · Olympus Hemostasis Devices · PAXLOVID · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · RUCONEST · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON · Utibron · Veklury · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
91
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
WINDMOOR HEALTHCARE OF CLEARWATER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Averill is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Averill experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Averill performed 687 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Averill receive payments from pharmaceutical companies?
Yes. Dr. Averill received a total of $287,113 from 59 companies across 1,373 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Averill's costs compare to other pulmonary diseases in Clearwater?
Dr. Averill's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Averill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Clearwater
Browse pulmonary diseases in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Insmed, Inc. Payments to Doctors
See all physicians who received payments from Insmed, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology